Results 71 to 80 of about 539 (92)

Surgical repositioning of a SING IMT following haptic dislocation: Restoration of alignment and visual function. [PDF]

Am J Ophthalmol Case Rep
Ameli S, Ní Dhubhghaill S, Vidal-Aroca F, Fasolino G.   +3 more
europepmc   +1 more source

Izervay versus Syfovre: Two Rivals Recently Approved for Management of Geographic Atrophy. [PDF]

Ann Afr Med
Patel H, Kutikuppala LVS, Sharma S, Chavan M, Rangari G, Misra AK, Rao KS.   +6 more
europepmc   +1 more source

Complement Inhibitors for Geographic Atrophy in Age-Related Macular Degeneration-A Systematic Review. [PDF]

J Pers Med
Dascalu AM, Grigorescu CC, Serban D, Tudor C, Alexandrescu C, Stana D, Jurja S, Costea AC, Alius C, Tribus LC, Dumitrescu D, Bratu D, Cristea BM.   +12 more
europepmc   +1 more source

Spiegelmer Aptamers: Innovative Approach in Breast Cancer. [PDF]

Breast Cancer (Auckl)
Amiri Hezave Y, Najafi R, Amini R, Shojaeian A.   +3 more
europepmc   +1 more source

Corrigendum to "Retinal Vasculitis After Intravitreal Pegcetacoplan: Report From the ASRS Research and Safety in Therapeutics (ReST) Committee". [PDF]

J Vitreoretin Dis
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration

Ophthalmology, 2021
Harvey Masonson, John Randolph, Keith Westby   +2 more
exaly  

Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

Lancet, The, 2023
Roberto Gallego-Pinazo, András Seres, Sunil Patel   +2 more
exaly  

Avacincaptad Pegol: First Approval

Drugs, 2023
Connie Kang
exaly